Patents by Inventor Isabelle Ziri

Isabelle Ziri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6992211
    Abstract: The subject-matter of the invention is the B form of ethyl [(7S)-7-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino]-5,6,7,8-tetrahydronaphth-2-yloxy]acetate hydrochloride, of use as a medicament, which exhibits in particular the following physical characteristics: characteristic IR absorption peaks (cm?1): 2780, 2736, 1722, 1211; melting point: 129+/?2° C.; characteristic lines of the powder X-ray diffraction diagram (to within 0.1(2?)): 7.69, 9.83, 13.95, 16.58, 18.70, 20.40, 21.57, 23.40, 24.15 and 25.64. The product can be obtained by salification of the base or recrystallization of the salt from an alcohol.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: January 31, 2006
    Assignee: Sanofi-Aventis
    Inventors: Antoine Caron, Olivier Monnier, Sabrina Obert, Jérome Roche, Isabelle Ziri
  • Publication number: 20040180953
    Abstract: The subject-matter of the invention is the B form of ethyl [(7S)-7-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino]-5,6,7,8-tetrahydronaphth-2-yloxy]acetate hydrochloride, of use as a medicament, which exhibits in particular the following physical characteristics:
    Type: Application
    Filed: May 3, 2004
    Publication date: September 16, 2004
    Inventors: Antoine Caron, Olivier Monnier, Sabarina Obert, Jerome Roche, Isabelle Ziri